A s a teen, Lecritia Roberts injected herself with insulin using a glass vial and a syringe to manage her type 1 diabetes, ...
Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.
Novo Nordisk has signed off on a $285 million biobucks deal with fellow Denmark-based company Ascendis Pharma to help the Wegovy manufacturer develop a once-monthly GLP-1 receptor agonist.
Novo Nordisk landed in hot water with the FDA following an inspection at one of the drugmaker’s key semaglutide and insulin manufacturing plants this past spring. | The FDA issued a ...
Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...
Novo Nordisk, the pharma giant behind Ozempic and Wegovy, has surprising love story origins. The founders, a married couple, were looking for a way to tackle diabetes, which the wife suffered from.
Novo Nordisk remains a sell due to increased competition ... with a 54.8% market share in GLP-1 and a 43.9% market share in insulin (33.8% total diabetes market share). As this share has grown ...
These naturally occurring hormones play crucial roles in regulating insulin ... marked doses on the pens (0.25, 0.5, 1.0 and ...
Novo Nordisk’s blockbuster Wegovy weight-loss drug beat sales expectations in the third quarter, sending shares 8.5% higher in early trade. Soaring popularity for its obesity drug has seen ...
The drug is used to treat type 2 diabetes and obesity and it works by mimicking the effects of the body’s natural hormone, ...
It seems like every day a new study emerges linking Ozempic and similar drugs to new health benefits. Ozempic is part of a drug class known as GLP-1 medications, which mimic gut hormones that help ...
The three largest insulin makers – Novo Nordisk, Sanofi and Eli Lilly - implemented ... Even after dramatic price cuts, a month's supply of injector pens may still cost more than $150.